Contract Pharma14d
CordenPharma to Establish New Peptide Manufacturing Facility in Switzerland
CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz.
Taiwan News9d
Cell Penetrating Peptide Market to Skyrocket from US$ 2.16 Billion in 2024 to US$ 8.12 Billion by 2033, Registering a Staggering 15.85% CAGR
The global Cell Penetrating Peptide Market is poised for exceptional growth, as it is projected to surge from US$ 2.16 billion in 2024 to an impressive US$ 8.12 billion by 2033, e ...
FiercePharma23d
India’s Granules makes $22M play for Senn Chemicals to enter peptides CDMO business
In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract manufacturer Senn Chemicals. The deal, once closed, will immediately ...
PolyPeptide with substantial improvements in profitability and cash flow, positioned for strong growth
In 2024, PolyPeptide made substantial progress in restoring profitability. The gross profit for 2024 was EUR 39.3 million versus EUR 9.1 million in 2023, and EBITDA was EUR 25.4 million versus EUR ...
Business Weekly13d
Constructive Bio wins fresh funding as it targets markets worth multibillions
Cambridge synthetic biology doyen Constructive Bio has been awarded a significant grant from Innovate UK to transform the ...